First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort
Crossref DOI link: https://doi.org/10.1186/s12985-015-0261-0
Published Online: 2015-03-03
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Werner, Christoph R
Franz, Carolin
Egetemeyr, Daniel P
Beck, Robert
Malek, Nisar P
Lauer, Ulrich M
Berg, Christoph P
License valid from 2015-03-03
Article History
Received: 31 July 2014
Accepted: 10 February 2015
First Online: 3 March 2015